OvaScience, Inc., a pioneering biotechnology company headquartered in the United States, focuses on advancing reproductive health through innovative solutions. Founded in 2011, OvaScience has made significant strides in the field of fertility, particularly with its proprietary technology aimed at enhancing egg quality and quantity for women facing infertility challenges. The company’s core offerings include the AUGMENT™ treatment, which utilises a woman’s own egg precursor cells to improve the chances of successful conception. This unique approach sets OvaScience apart in the competitive fertility industry, positioning it as a leader in reproductive science. With a commitment to research and development, OvaScience continues to explore new avenues for improving reproductive outcomes, solidifying its reputation as a key player in the global fertility market.
How does OvaScience, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
OvaScience, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OvaScience, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. It is important to note that OvaScience, Inc. is a merged entity, and any potential emissions data or climate commitments may be cascaded from its corporate family. However, no specific information regarding such data or commitments has been provided. In the context of the industry, OvaScience, Inc. may benefit from adopting industry-standard climate initiatives and targets to enhance its sustainability profile. As of now, the company has not established any publicly available climate commitments or reduction initiatives.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 27,475,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 37,395,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OvaScience, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
